Pfizer's open data policy should include trials of off-label uses, say critics.
作者信息
Kmietowicz Zosia
机构信息
BMJ.
出版信息
BMJ. 2013 Dec 6;347:f7327. doi: 10.1136/bmj.f7327.
PMID:24319259
Abstract
摘要
相似文献
1
Pfizer's open data policy should include trials of off-label uses, say critics.批评人士称，辉瑞的开放数据政策应涵盖对药物标签外用途的试验。
BMJ. 2013 Dec 6;347:f7327. doi: 10.1136/bmj.f7327.
2
EFPIA-PhRMA's principles for clinical trial data sharing have been misunderstood.欧洲制药工业协会联合会-美国制药研究与制造商协会的临床试验数据共享原则被误解了。
BMJ. 2013 Aug 20;347:f5164. doi: 10.1136/bmj.f5164.
3
Dissemination of information on the off-label (unapproved) use of medication: a comparative analysis.关于药物未获批准用途信息的传播：一项比较分析。
Med Law. 2011 Mar;30(1):115-32.
4
FDA draft guidance on adaptive design clinical trials: Pfizer's perspective.美国食品药品监督管理局关于适应性设计临床试验的草案指南：辉瑞公司的观点。
J Biopharm Stat. 2010 Nov;20(6):1143-9. doi: 10.1080/10543406.2010.514456.
5
EMA's proposal to vet drug research that uses its data is "outdated," say critics.批评人士称，欧洲药品管理局（EMA）关于审查使用其数据的药物研究的提议“过时了”。
BMJ. 2014 Aug 10;349:g5076. doi: 10.1136/bmj.g5076.
6
Media coverage of off-label promotion: a content analysis of US newspapers.媒体对标签外推广的报道：对美国报纸的内容分析。
Res Social Adm Pharm. 2011 Sep;7(3):257-71. doi: 10.1016/j.sapharm.2010.06.003. Epub 2010 Nov 25.
7
The e-recruitment of participants for clinical trials.
IRB. 2003 Jul-Aug;25(4):16-7.
8
The future of off-label marketing regulations in the post-Sorrell era.索雷尔时代之后非标签营销法规的未来。
Seton Hall Law Rev. 2013;43(3):1137-63.
9
Redacted policy on sharing drug trial data in Europe.欧洲药品试验数据共享的修订政策。
BMJ. 2014 May 28;348:g3561. doi: 10.1136/bmj.g3561.
10
Recommendations for clinical trials of off-label drugs used to treat advanced-stage cancer.晚期癌症治疗中应用超适应证药物的临床试验推荐建议。
J Clin Oncol. 2012 Feb 20;30(6):661-6. doi: 10.1200/JCO.2011.35.5198. Epub 2012 Jan 17.
Zotero 插件